Anti-radiation Drugs Market to Surpass US$ 9.6 Billion by 2031, Driven by Rising Cancer Incidence, Nuclear Preparedness, and Advances in Radiation Countermeasures
The global anti-radiation drugs market is witnessing substantial growth as governments, healthcare organizations, and biotechnology companies strengthen their preparedness against radiological emergencies while expanding treatment options for cancer patients undergoing radiation therapy. According to the latest market analysis, the industry was valued at US$ 3.4 billion in 2021 and is projected...
0 Comments 0 Shares 60 Views 0 Reviews